J99 is a billable/specific diagnosis code from the 2025 ICD-10-CM used to classify the following condition: Respiratory disorders in diseases classified elsewhere.
Code first
Type 1 excludes
Respiratory disorders in:
Amebiasis (A06.5)
Blastomycosis (B40.0-B40.2)
Candidiasis (B37.1)
Coccidioidomycosis (B38.0-B38.2)
Cystic fibrosis with pulmonary manifestations (E84.0)
Histoplasmosis (B39.0-B39.2)
Polymyositis (M33.21)
Sju00f6gren syndrome (M35.02)
Systemic lupus erythematosus (M32.13)
Systemic sclerosis (M34.81)
Wegener's granulomatosis (M31.30-M31.31)
Versions
2025
Code changed
Type 1 excludes
respiratory disorders in:amebiasis (A06.5)blastomycosis (B40.0-B40.2)candidiasis (B37.1)coccidioidomycosis (B38.0-B38.2)cystic fibrosis with pulmonary manifestations (E84.0)dermatomyositis (M33.01, M33.11)histoplasmosis (B39.0-B39.2)late syphilis (A52.72, A52.73)polymyositis (M33.21)Sjögren syndrome (M35.02)systemic lupus erythematosus (M32.13)systemic sclerosis (M34.81)Wegener's granulomatosis (M31.30-M31.31)
- respiratory disorders in:
- amebiasis (A06.5)
- blastomycosis (B40.0-B40.2)
- candidiasis (B37.1)
- coccidioidomycosis (B38.0-B38.2)
- cystic fibrosis with pulmonary manifestations (E84.0)
- dermatomyositis (M33.01, M33.11)
- histoplasmosis (B39.0-B39.2)
- late syphilis (A52.72, A52.73)
- polymyositis (M33.21)
- Sju00f6gren syndrome (M35.02)
- systemic lupus erythematosus (M32.13)
- systemic sclerosis (M34.81)
- Wegener's granulomatosis (M31.30-M31.31)
2024
Code changed
Code first
underlying disease, such as:amyloidosis (E85.-)ankylosing spondylitis (M45)congenital syphilis (A50.5)cryoglobulinemia (D89.1)early congenital syphilis (A50.0)plasminogen deficiency (E88.02)schistosomiasis (B65.0-B65.9)
- underlying disease, such as:
- amyloidosis (E85.-)
- ankylosing spondylitis (M45.-)
- congenital syphilis (A50.-)
- cryoglobulinemia (D89.1)
- early congenital syphilis (A50.0-)
- plasminogen deficiency (E88.02)
- schistosomiasis (B65.0-B65.9)
2023
No changes
2022
Code changed
Type 1 excludes
respiratory disorders in:amebiasis (A06.5)blastomycosis (B40.0-B40.2)candidiasis (B37.1)coccidioidomycosis (B38.0-B38.2)cystic fibrosis with pulmonary manifestations (E84.0)dermatomyositis (M33.01, M33.11)histoplasmosis (B39.0-B39.2)late syphilis (A52.72, A52.73)polymyositis (M33.21)sicca syndrome (M35.02)systemic lupus erythematosus (M32.13)systemic sclerosis (M34.81)Wegener's granulomatosis (M31.30-M31.31)
- respiratory disorders in:
- amebiasis (A06.5)
- blastomycosis (B40.0-B40.2)
- candidiasis (B37.1)
- coccidioidomycosis (B38.0-B38.2)
- cystic fibrosis with pulmonary manifestations (E84.0)
- dermatomyositis (M33.01, M33.11)
- histoplasmosis (B39.0-B39.2)
- late syphilis (A52.72, A52.73)
- polymyositis (M33.21)
- Sjögren syndrome (M35.02)
- systemic lupus erythematosus (M32.13)
- systemic sclerosis (M34.81)
- Wegener's granulomatosis (M31.30-M31.31)
2021
No changes
2020
No changes
2019
Code changed
Code first
underlying disease, such as:amyloidosis (E85.-)ankylosing spondylitis (M45)congenital syphilis (A50.5)cryoglobulinemia (D89.1)early congenital syphilis (A50.0)schistosomiasis (B65.0-B65.9)
- underlying disease, such as:
- amyloidosis (E85.-)
- ankylosing spondylitis (M45)
- congenital syphilis (A50.5)
- cryoglobulinemia (D89.1)
- early congenital syphilis (A50.0)
- plasminogen deficiency (E88.02)
- schistosomiasis (B65.0-B65.9)
2018
No changes
2017
No changes
2016
New code